Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Estrella Immunopharma, Inc.

News headline image
Estrella Advances STARLIGHT-1 Trial into Phase II Following Positive DSMB Recommendation
From Estrella Immunopharma, Inc.
Via Business Wire
Tickers ESLA
News headline image
Estrella Immunopharma Completes Second Dose Cohort in STARLIGHT-1 Trial of EB103 with Complete Responses in All Evaluable Patients
From Estrella Immunopharma, Inc.
Via Business Wire
Tickers ESLA
News headline image
Estrella Immunopharma Regains Compliance with Nasdaq Listing Requirements
From Estrella Immunopharma, Inc.
Via Business Wire
Tickers ESLA
News headline image
Estrella Immunopharma Announces Activation of Additional Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma
From Estrella Immunopharma, Inc.
Via Business Wire
Tickers ESLA
News headline image
Estrella Immunopharma Announces Approximately $3.35 Million Private Placement Equity Financing
From Estrella Immunopharma, Inc.
Via Business Wire
Tickers ESLA
News headline image
Estrella Immunopharma Initiates Second Cohort and Doses First Patient in STARLIGHT-1 Trial of EB103 in Advanced B-Cell Non-Hodgkin’s Lymphomas
From Estrella Immunopharma, Inc.
Via Business Wire
Tickers ESLA
News headline image
Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Buy Rating With a Price Target of $14.00 From CB Capital Partners
From Estrella Immunopharma, Inc.
Via Business Wire
Tickers ESLA
News headline image
Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) Receives Buy Rating with a 12-Month Price Target of $16.00 from D. Boral Capital
From Estrella Immunopharma, Inc.
Via Business Wire
Tickers ESLA ESLAW
News headline image
Estrella Immunopharma Achieves Complete Response in First Patient Treated with CD19- Redirected ARTEMIS® T-cells
From Estrella Immunopharma, Inc.
Via Business Wire
Tickers ESLA ESLAW
News headline image
Estrella Immunopharma Announces Appointment of Hong Zhang as Chairperson and Board Member
From Estrella Immunopharma, Inc.
Via Business Wire
Tickers ESLA ESLAW
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.